We are live on ! Find out more
MDCO

Medicines Co
MDCO

Delisted

MDCO was delisted on the 3rd of January, 2020.

Back to rankings

1 hedge funds and large institutions have $66K invested in Medicines Co in 2020 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 278 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 284 → 1 (-283)

100% less funds holding in top 10

Funds holding in top 10: 38 → 0 (-38)

100% less capital invested

Capital invested by funds: $8.36B → $66K (-$8.36B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 278

Holders
1
Holders Change
-283
Holders Change %
-99.65%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-38
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
278
Calls
$12.9M
Puts
–
Net Calls
+$12.9M
Net Calls Change
-$160M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$1.03B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$648M
3
SCM
Sarissa Capital Management
Connecticut
-$357M
4
HI
HBK Investments
Texas
-$330M
5
FCM
Farallon Capital Management
California
-$282M
Name Holding Trade Value Shares
Change 		Change in
Stake
N
51
Nuveen
North Carolina
– -$41.4M -487,815 Closed
Charles Schwab
52
Charles Schwab
California
– -$39M -459,105 Closed
SG Americas Securities
53
SG Americas Securities
New York
– -$37M -435,741 Closed
Wellington Management Group
54
Wellington Management Group
Massachusetts
– -$36.6M -431,152 Closed
Invesco
55
Invesco
Georgia
– -$35.9M -422,563 Closed
RA
56
Ramius Advisors
New York
– -$35.7M -419,826 Closed
BHMP
57
Bardin Hill Management Partners
New York
– -$35.3M -415,862 Closed
First Eagle Investment Management
58
First Eagle Investment Management
New York
– -$34.8M -409,112 Closed
FCMI
59
Foresite Capital Management IV
California
– -$34.2M -403,217 Closed
Allianz Asset Management
60
Allianz Asset Management
Germany
– -$31.7M -372,944 Closed
Walleye Trading
61
Walleye Trading
New York
– -$29.8M -350,318 Closed
GCIA
62
Gabelli & Co Investment Advisers
New York
– -$29.2M -343,710 Closed
CM
63
Caption Management
Oklahoma
– -$28.3M -333,600 Closed
Barclays
64
Barclays
United Kingdom
– -$27.6M -325,106 Closed
AA
65
Antipodean Advisors
New York
– -$27.3M -321,000 Closed
MFS
66
Mirabella Financial Services
United Kingdom
– -$26.3M -310,000 Closed
RSCM
67
Rock Springs Capital Management
Maryland
– -$26.1M -307,699 Closed
BM
68
Bridger Management
New York
– -$25.9M -305,002 Closed
Alyeska Investment Group
69
Alyeska Investment Group
Illinois
– -$25.6M -300,943 Closed
GIM
70
Granahan Investment Management
Massachusetts
– -$23.4M -275,712 Closed
OAM
71
Oxford Asset Management
United Kingdom
– -$23M -271,046 Closed
Public Sector Pension Investment Board (PSP Investments)
72
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
– -$22.5M -265,373 Closed
RhumbLine Advisers
73
RhumbLine Advisers
Massachusetts
– -$22.1M -260,584 Closed
WSC
74
White Square Capital
United Kingdom
– -$20.3M -239,331 Closed
MAM
75
Melqart Asset Management
United Kingdom
– -$20.3M -239,000 Closed
1 2
3
4 5

MDCO Hedge Fund Activity: Q1 2020 in Review

1 of the 4,539 institutional investors tracked by Wall St. Rank reported a position in Medicines Co (MDCO) for Q1 2020, worth a combined $66K — down 100% from $8.36B a quarter earlier.

Sellers outnumbered buyers: 278 funds closed out of MDCO and 0 opened new positions — a net loss of 278 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $1.03B sold.

  • 1 institutional investor held Medicines Co (MDCO) as of Q1 2020, down from 284 in Q4 2019.
  • Funds reported $66K of Medicines Co stock for Q1 2020, down 100% quarter-over-quarter.
  • 0 funds opened new Medicines Co positions in Q1 2020 and 278 closed out, a net change of -278 holders.
  • The largest Medicines Co seller in Q1 2020 was BlackRock, an estimated $1.03B sold.

Based on aggregated 13F filings for Q1 2020.